Numerous studies have demonstrated that CTRP9 has anti-inflammatory properties and modulates inflammatory responses, thereby attenuating EC dysfunction in PAH.196,197 Over-expression of CTRP9 significantly mitigates inflammation, apoptosis, and ECM accumulation in PAH by activating the Akt pathway.198. This evidence concerns the gene AKT1 and pulmonary arterial hypertension.